Literature DB >> 17509522

Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes.

Melvin E Klegerman1, Shaoling Huang, Devang Parikh, Janet Martinez, Sasha M Demos, Hayat A Onyuksel, David D McPherson.   

Abstract

Immunoliposomes, directed to clinically relevant cell-surface molecules with antibodies, antibody fragments or peptides, are used for site-specific diagnostic evaluation or delivery of therapeutic agents. We have developed intrinsically echogenic liposomes (ELIP) covalently linked to fibrin(ogen)-specific antibodies and Fab fragments for ultrasonic imaging of atherosclerotic plaques. In order to determine the effect of liposomal conjugation on the molecular dynamics of fibrinogen binding, we studied the thermodynamic characteristics of unconjugated and ELIP-conjugated antibody molecules. Utilizing radioimmunoassay and enzyme-linked immunosorbent assay protocols, binding affinities were derived from data obtained at three temperatures. The thermodynamic functions DeltaH(o) , DeltaG(o) and DeltaS(o) were determined from van't Hoff plots and equations of state. The resultant functions indicated that both specific and nonspecific associations of antibody molecules with fibrinogen occurred through a variety of molecular interactions, including hydrophophic, ionic and hydrogen bonding mechanisms. ELIP conjugation of antibodies and Fab fragments introduced a characteristic change in both DeltaH(o) and DeltaS(o) of association, which corresponded to a variable contribution to binding by phospholipid gel-liquid crystal phase transitions. These observations suggest that a reciprocal energy transduction, affecting the strength of antibody-antigen binding, may be a singular characteristic of immunoliposomes, having utility for optimization and further development of the technology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509522      PMCID: PMC2039706          DOI: 10.1016/j.bbamem.2007.04.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  47 in total

1.  The molecular heterogeneity and instability of radioiodinated human chorionic gonadotrophin.

Authors:  B W Griffiths; A Godard
Journal:  Clin Biochem       Date:  1975-12       Impact factor: 3.281

2.  A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation.

Authors:  Ronen Ben-Ami; Gershon Barshtein; Tamar Mardi; Varda Deutch; Ori Elkayam; Saul Yedgar; Shlomo Berliner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-17       Impact factor: 4.733

3.  Mutations of an epitope hot-spot residue alter rate limiting steps of antigen-antibody protein-protein associations.

Authors:  Y Li; C A Lipschultz; S Mohan; S J Smith-Gill
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

4.  The immunochemistry of solid-phase sandwich enzyme-linked immunosorbent assays.

Authors:  J E Butler; J H Peterman; M Suter; S E Dierks
Journal:  Fed Proc       Date:  1987-06

5.  Quantitative immunoblot assay for assessment of liposomal antibody conjugation efficiency.

Authors:  Melvin E Klegerman; Andrew J Hamilton; Shao-Ling Huang; Susan D Tiukinhoy; Amer A Khan; Robert C MacDonald; David D McPherson
Journal:  Anal Biochem       Date:  2002-01-01       Impact factor: 3.365

6.  VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery.

Authors:  S Dagar; M Sekosan; B S Lee; I Rubinstein; H Onyüksel
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

7.  Hypoglycaemia due to insulin autoimmune syndrome: report of two cases with characterisation of HLA alleles and insulin autoantibodies.

Authors:  B Cavaco; Y Uchigata; T Porto; M Amparo-Santos; L Sobrinho; V Leite
Journal:  Eur J Endocrinol       Date:  2001-09       Impact factor: 6.664

8.  VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies.

Authors:  Sumeet Dagar; Aparna Krishnadas; Israel Rubinstein; Michael J Blend; Hayat Onyüksel
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

9.  Convenient and effective method for removing fibrinogen from serum specimens before protein electrophoresis.

Authors:  Ling L Qiu; Stanley S Levinson; Kristen L Keeling; Ronald J Elin
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

10.  Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model.

Authors:  Andrew Hamilton; Shao-Ling Huang; Drew Warnick; Adam Stein; Mark Rabbat; Taruna Madhav; Bonnie Kane; Ashwin Nagaraj; Melvin Klegerman; Robert MacDonald; David McPherson
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

View more
  6 in total

Review 1.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

2.  In vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes.

Authors:  Hyunggun Kim; Melanie R Moody; Susan T Laing; Patrick H Kee; Shao-Ling Huang; Melvin E Klegerman; David D McPherson
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

3.  Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model.

Authors:  Kathryn E Hitchcock; Danielle N Caudell; Jonathan T Sutton; Melvin E Klegerman; Deborah Vela; Gail J Pyne-Geithman; Todd Abruzzo; Peppar E P Cyr; Yong-Jian Geng; David D McPherson; Christy K Holland
Journal:  J Control Release       Date:  2010-03-02       Impact factor: 9.776

4.  Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progression.

Authors:  Melvin E Klegerman; Ali K Naji; Kevin J Haworth; Yuejiao Zou; Eva Golunski; Tao Peng; George L Britton; Shao-Ling Huang; Christy K Holland; David D McPherson
Journal:  J Liposome Res       Date:  2015-04-13       Impact factor: 3.648

5.  Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics.

Authors:  Melvin E Klegerman; Michael Wassler; Shao-Ling Huang; Yuejiao Zou; Hyunggun Kim; Harnath S Shelat; Christy K Holland; Yong-Jian Geng; David D McPherson
Journal:  J Control Release       Date:  2009-11-10       Impact factor: 9.776

6.  Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1.

Authors:  Stephanie M Herbst; Melvin E Klegerman; Hyunggun Kim; Jiangbo Qi; Harnath Shelat; Michael Wassler; Melanie R Moody; Chen-Min Yang; Xinyi Ge; Yuejiao Zou; Jonathan A Kopechek; Fred J Clubb; Duane C Kraemer; Shaoling Huang; Christy K Holland; David D McPherson; Yong-Jian Geng
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.